AbbVie Inc. closed 5.34% below its 52-week high of $207.32, which the company reached on October 31st.

We recently compiled a list of the Top 10 Stocks to Buy According to Lee Munder Capital Group. In this article, we are going ...

AbbVie just rewarded its shareholders again with a dividend. This stock has boosted its payout annually for more than 50 ...

DCF analysis, a reliable and data-driven approach to estimating its intrinsic value. Instead of using future free cash flow ...

Large American pharmaceutical companies are showing a distinct trend never seen before: they are increasingly looking for ...

AbbVie Inc. offers a combination of rock-solid business mix, aggressive growth strategy, and shareholder-friendly capital allocation. The company holds strong positions in rapidly growing markets ...

Every investor in AbbVie Inc. ( NYSE:ABBV) should be aware of the most powerful shareholder groups. The group holding the most number of shares in the company, around 73% to be precise, is ...

Equities research analysts at Leerink Partnrs issued their Q1 2025 earnings per share (EPS) estimates for shares of AbbVie in a research note issued to investors on Monday, February 3rd. Leerink ...

AbbVie Inc. (NYSE:ABBV – Get Free Report) was the target of unusually large options trading activity on Monday. Stock investors purchased 39,550 call options on the stock. This is an increase of ...

While some investors are already well versed in financial metrics (hat tip), this article is for those who would ...